Two existing drugs prevent COVID-19 in human cells: Study


PTI, Aug 18, 2020, 1:37 PM IST

Boston: Two existing drugs inhibit SARS-CoV-2, the virus that causes COVID-19, from infecting human cells in the lab, a study has found.

According to the study, published in the journal PNAS, both drugs, vacuolin-1, and apilimod, originally developed years ago, target a large enzyme called PIKfyve kinase.

“Before this study, little was known about this enzyme”s role in COVID-19 infection,” the researchers said.

“The work, which will need to be replicated in human trials, suggests a potential new target for COVID-19 therapies,” they said.

“Our findings show that targeting this kinase through a small-molecule antiviral against SARS-CoV-2 may be an effective strategy to lessen the progression or seriousness of COVID-19,” said study co-senior author Tomas Kirchhausen, a professor at the Harvard Medical School (HMS) in the US.

Kirchhausen said that he discovered vacuolin-1 16 years ago, while apilimod was developed by a company called LAM Therapeutics.

Kirchhausen performed cell biology studies with the SARS-CoV-2 virus in the lab of Sean Whelan, who had been part of the Center for Excellence team at HMS.

“Within a week, we knew apilimod worked extremely well in preventing SARS-CoV-2 infection in human cells in the lab,” said Kirchhausen, who initially published this discovery on the bioRxiv pre-print website in April 2020.

That pre-print also included a review of apilimod”s effectiveness against Ebola and SARS-CoV-2.

“We found that like apilimod, vacuolin-1 is a very strong inhibitor for viral infection in the lab,” said Kirchhausen.

The HMS researchers noted that an unrelated group has published a paper in the journal Nature, showing that, in a screen of 12,000 clinical-stage or FDA-approved small molecules, apilimod was one of the best drugs for inhibiting SARS-CoV-2 virus replication.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

PM Modi and Russian President Putin discuss state of global energy & food markets

Senior Congress leader draws flak for remark on former PM Deve Gowda

Stolen 17th century Tamil bible traced to London after 17 years

Army, Navy begin recruitment under Agnipath scheme

Datta Peeta issue: State cabinet gives nod for appointing Hindu priest

Sindhu loses to nemesis Tai Tzu Ying, Prannoy also exits from Malaysia Open

Shivamogga: At least 40 injured as buses collide head-on


Related Articles More

How your brainwaves could be used in criminal trials

ISRO successfully launches PSLV-C53 with three Singapore satellites onboard

The iPhone turns 15: A look at the past (and future) of one of the 21st century’s most influential devices

54% in India turn to social media for factual info: OUP study

CERT-In gives more time for VPNs to comply with new cyber security norms

MUST WATCH

How to earn God’s grace?

NEW BULLETIN 01-07-2022

Heavy Rain Mallar Urdu school Damage

Heavy rain at kaup area

Banana cultivation : Success story of a farmer


Latest Additions

PM Modi and Russian President Putin discuss state of global energy & food markets

Senior Congress leader draws flak for remark on former PM Deve Gowda

Stolen 17th century Tamil bible traced to London after 17 years

Bantwal: Father-son duo arrested for running Illegal cattle slaughterhouse

Army, Navy begin recruitment under Agnipath scheme

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.